Cargando…

Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition

Molecules that have a reactive functional group within a macrocycle represent a class of covalent inhibitor. The relationship between reactivity and affinity for the target is cooperative and complicated. An understanding and characterization of this class of inhibitor are vital for the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitahata, S., Yakushiji, F., Ichikawa, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642145/
https://www.ncbi.nlm.nih.gov/pubmed/29147522
http://dx.doi.org/10.1039/c7sc02941a
_version_ 1783271321912737792
author Kitahata, S.
Yakushiji, F.
Ichikawa, S.
author_facet Kitahata, S.
Yakushiji, F.
Ichikawa, S.
author_sort Kitahata, S.
collection PubMed
description Molecules that have a reactive functional group within a macrocycle represent a class of covalent inhibitor. The relationship between reactivity and affinity for the target is cooperative and complicated. An understanding and characterization of this class of inhibitor are vital for the development of covalent inhibitors as drug candidates. Herein, we describe a systematic analysis of structure–activity relationships using a series of syringolin analogues, which are irreversible covalent inhibitors of proteasomes. We investigate the detailed mechanistic effects of the macrocycles on affinity and reaction rate.
format Online
Article
Text
id pubmed-5642145
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-56421452017-11-16 Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition Kitahata, S. Yakushiji, F. Ichikawa, S. Chem Sci Chemistry Molecules that have a reactive functional group within a macrocycle represent a class of covalent inhibitor. The relationship between reactivity and affinity for the target is cooperative and complicated. An understanding and characterization of this class of inhibitor are vital for the development of covalent inhibitors as drug candidates. Herein, we describe a systematic analysis of structure–activity relationships using a series of syringolin analogues, which are irreversible covalent inhibitors of proteasomes. We investigate the detailed mechanistic effects of the macrocycles on affinity and reaction rate. Royal Society of Chemistry 2017-10-01 2017-08-11 /pmc/articles/PMC5642145/ /pubmed/29147522 http://dx.doi.org/10.1039/c7sc02941a Text en This journal is © The Royal Society of Chemistry 2017 http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported License (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Chemistry
Kitahata, S.
Yakushiji, F.
Ichikawa, S.
Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition
title Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition
title_full Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition
title_fullStr Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition
title_full_unstemmed Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition
title_short Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition
title_sort impact of the structures of macrocyclic michael acceptors on covalent proteasome inhibition
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642145/
https://www.ncbi.nlm.nih.gov/pubmed/29147522
http://dx.doi.org/10.1039/c7sc02941a
work_keys_str_mv AT kitahatas impactofthestructuresofmacrocyclicmichaelacceptorsoncovalentproteasomeinhibition
AT yakushijif impactofthestructuresofmacrocyclicmichaelacceptorsoncovalentproteasomeinhibition
AT ichikawas impactofthestructuresofmacrocyclicmichaelacceptorsoncovalentproteasomeinhibition